Microparticle-associated nucleic acids mediate trait dominance in cancer

FASEB Journal

Volumn 26, Issue 1, 2012, Pages 420-429

  Jaiswal, Ritu ^a,b   Gong, Joyce ^a,b   Sambasivam, Shwetha ^b   Combes, Valery ^a   Mathys, Jean Marie ^c   Davey, Ross ^d   Grau, Georges E R ^a   Bebawy, Mary ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Intercellular transfer; Multidrug resistance; Multidrug resistance associated protein 1; P glycoprotein

Indexed keywords

GLYCOPROTEIN P; MICRORNA; MULTIDRUG RESISTANCE PROTEIN 1;

ANTIBODY LABELING; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL POPULATION; CELL STRAIN MCF 7; CONTROLLED STUDY; CROSS RESISTANCE; DOMINANT INHERITANCE; DONOR; DONOR SELECTION; DRUG SENSITIVITY; GENE DELETION; GENE OVEREXPRESSION; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA; MEMBRANE MICROPARTICLE; MULTIDRUG RESISTANCE; ONCOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN TRANSPORT; REAL TIME POLYMERASE CHAIN REACTION; RECIPIENT; RNA TRANSCRIPTION; TREATMENT FAILURE;

ADENOCARCINOMA; BREAST NEOPLASMS; CELL COMMUNICATION; CELL LINE, TUMOR; CELL-DERIVED MICROPARTICLES; COCULTURE TECHNIQUES; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MICRORNAS; MICROSCOPY, ELECTRON, SCANNING; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NUCLEIC ACIDS; PHENOTYPE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTEIN TRANSPORT;

EID: 84855389040     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-186817     Document Type: Article

References (44)

1. Longley, D., and Johnston, P. (2005) Molecular mechanisms of drug resistance. J. Pathol. 205, 275-292 (Pubitemid 40227997)
2. Longo-Sorbello, G., and Bertino, J. R. (2001) Current understanding of methotrexate pharmacology and efficacy in acute leukemias. Use of newer antifolates in clinical trials. Haematologica 86, 121-127 (Pubitemid 32216083)
3. Biedler, J. L., and Riehm, H. (1970) Cellular resistance to actinomycin D in chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Res. 30, 1174-1184
4. Linn, S. C., Giaccone, G., van Diest, P. J., Blokhuis, W. M. D., van der Valk, P., van Kalken, C. K., Kuiper, C. M., Pinedo, H. M., and Baak, J. P. A. (1995) Prognostic relevance of P-glycoprotein expression in breast cancer. Ann. Oncol. 6, 679-685
5. Goasguen, J., Dossot, J., Fardel, O., Le Mee, F., Le Gall, E., Leblay, R., LePrise, P., Chaperon, J., and Fauchet, R. (1993) Expression of the multidrug resistance-associated P-glycoprotein (P- 170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications [see comments]. Blood 81, 2394-2398 (Pubitemid 23127076)
6. Lee, G., and Bendayan, R. (2004) Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders. Pharm. Res. 21, 1313-1330 (Pubitemid 39149646)
7. Shi, H., Lu, D., Shu, Y., Shi, W., Lu, S., and Wang, K. (2008) Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S- transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Cancer Invest. 26, 344-351 (Pubitemid 351601390)
8. Munoz, M., Henderson, M., Haber, M., and Norris, M. (2007) Role of the MRP1/ABCC1 multidrug transporter protein in cancer. IUBMB Life 59, 752-757 (Pubitemid 351412076)
9. Nooter, K., de la Riviere, G. B., Klijn, J., Stoter, G., and Foekens, J. (1997) Multidrug resistance protein in recurrent breast cancer. Lancet 349, 1885-1886 (Pubitemid 27270127)
10. Bebawy, M., Combes, V., Lee, E., Jaiswal, R., Gong, J., Bonhoure, A., and Grau, G. E. R (2009) Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells. Leukemia 23, 1643-1649
11. Distler, J. H., Huber, L. C., Gay, S., Distler, O., and Pisetsky, D. S. (2006) Microparticles as mediators of cellular cross-talk in inflammatory disease. Autoimmunity 39, 683-690 (Pubitemid 44964371)
12. Freyssinet, J. M. (2003) Cellular microparticles: what are they bad or good for? J. Thromb. Haemost. 1, 1655-1662
13. Bianco, F., Perrotta, C., Novellino, L., (2009) Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J. 28, 1043-1054
14. MacKenzie, A., Wilson, H. L., Kiss-Toth, E., Dower, S. K., North, R. A., and Surprenant, A. (2001) Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 15, 825-835 (Pubitemid 34008509)
15. Smalley, D. M., Root, K. E., Cho, H., Ross, M. M., and Ley, K. (2007) Proteomic discovery of 21 proteins expressed in human plasma-derived but not platelet-derived microparticles. Thromb. Haemost. 97, 67-80 (Pubitemid 46242388)
16. Mack, M., Kleinschmidt, A., Brühl, H., Klier, C., Nelson, P. J., Cihak, J., Plachý, J., Stangassinger, M., Erfle, V., and Schlöndorff, D. (2000) Transfer of the chemokine receptor CCR5 between cells by membrane- derived microparticles: A mechanism for cellular human immunodeficiency virus 1 infection. Nat. Med. 6, 769-775 (Pubitemid 30469425)
17. Zhang, Y., Liu, D., Chen, X., Li, J., Li, L., Bian, Z., Sun, F., Lu, J., Yin, Y., Cai, X., Sun, Q., Wang, K., Ba, Y., Wang, Q., Wang, D., Yang, J., Liu, P., Xu, T., Yan, Q., Zhang, J., Zen, K., and Zhang, C. Y. (2010) Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell. 39, 133-144
18. Camussi, G., Deregibus, M., Bruno, S., Grange, C., Fonsato, V., and Tetta, C. (2011) Exosome/microvesicle-mediated epigenetic reprogramming of cells. Am. J. Cancer Res. 1, 98-110
19. Lane, J. D., Allan, V. J., and Woodman, P. G. (2005) Active relocation of chromatin and endoplasmic reticulum into blebs in late apoptotic cells. J. Cell Sci. 118, 4059-4071 (Pubitemid 41410287)
20. Schiller, M., Bekeredjian-Ding, I., Heyder, P., Blank, N., Ho, A. D., and Lorenz, H. M. (2007) Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis. Cell Death Differ. 15, 183-191 (Pubitemid 350286186)
21. Reich, III C. F., and Pisetsky, D. S. (2009) The content of DNA and RNA in microparticles released by Jurkat and HL-60 cells undergoing in vitro apoptosis. Exp. Cell Res. 315, 760-768
22. Baj-Krzyworzeka, M., Szatanek, R., Weglarczyk, K., Baran, J., Urbanowicz, B., Brański, P., Ratajczak, M. Z., and Zembala, M. (2006) Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol. Immunother. 55, 808-818
23. Skog, J., Würdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Sena-Esteves, M., Curry, W. T. Jr., Carter, B. S., Krichevsky, A. M., and Breakefield, X. O. (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10, 1470-1476
24. Taylor, D. D., and Gercel-Taylor, C. (2008) MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol. 110, 13-21 (Pubitemid 351853251)
25. Tesselaar, M. E., Romijn, F. P., van der Linden, I. K., Bertina, R. M., and Osanto, S. (2009) Microparticle-associated tissue factor activity in cancer patients with and without thrombosis. J. Thromb. Haemost. 7, 1421-1423
26. Zhao, Y., and Srivastava, D. (2007) A developmental view of microRNA function. Trends Biochem. Sci. 32, 189-197 (Pubitemid 46603281)
27. Lewis, B. P., Burge, C. B., and Bartel, D. P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20 (Pubitemid 40094598)
28. Schickel, R., Boyerinas, B., Park, S. M., and Peter, M. E. (2008) MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 27, 5959-5974
29. Tsang, W. P., and Kwok, T. T. (2008) Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3. Apoptosis 13, 1215-1222
30. Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J. J., and Lotvall, J. O. (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659 (Pubitemid 47214727)
31. Yuan, A., Farber, E. L., Rapoport, A. L., Tejada, D., Deniskin, R., Akhmedov, N. B., and Farber, D. B. (2009) Transfer of microRNAs by embryonic stem cell microvesicles. PLoS One.4, e4722
32. Hunter, M. P., Ismail, N., Zhang, X., Aguda, B. D., Lee, E. J., Yu, L., Xiao, T., Schafer, J., Lee, M. L., Schmittgen, T. D., Nana-Sinkam, S. P., Jarjoura, D., and Marsh, C. B. (2008) Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 3, e3694
33. Gong, J., Jaiswal, R., Mathys, J. M., Combes, V., Grau, G. E., and Bebawy, M. (2011) Microparticles and their emerging role in cancer multidrug resistance. [E-pub ahead of print] Cancer Treat. Rev. doi: 10.1016/j.ctrv.2011. 06.005
34. Del Conde, I., Shrimpton, C. N., Thiagarajan, P., and López, J. A. (2005) Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106, 1604-1611 (Pubitemid 41208572)
35. Bebawy, M., Morris, M. B., and Roufogalis, B. D. (1999) A continuous fluorescence assay for the study of P-glycoprotein-mediated drug efflux using inside-out membrane vesicles. Anal. Biochem. 268, 270-277 (Pubitemid 29147142)
36. Bebawy, M., Morris, M. B., and Roufogalis, B. D. (2001) Selective modulation of P-glycoprotein-mediated drug resistance. Br. J. Cancer. 85, 1998-2003 (Pubitemid 34775339)
37. Dönmez, Y., Akhmetova, L., İşeri, Ö. D., Kars, M. D., and Gündüz, U. (2011) Effect of MDR modulators verapamil and promethazine on gene expression levels of MDR1 and MRP1 in doxorubicin-resistant MCF-7 cells. Cancer Chemother. Pharmacol. 67, 823-828
38. Combes, V., Simon, A. C., Grau, G. E., Arnoux, D., Camoin, L., Sabatier, F., Mutin, M., Sanmarco, M., Sampol, J., and Dignat- George, F. (1999) In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J. Clin. Invest. 104, 93-102 (Pubitemid 29534349)
39. Mi, Y., and Lou, L. (2007) ZD6474 reverses multidrug resistance by directly inhibiting the function of P-glycoprotein. Br. J. Cancer 97, 934-940 (Pubitemid 47519322)
40. Oerlemans, R., van der Heijden, J., Vink, J., Dijkmans, B. A., Kaspers, G. J., Lems, W. F., Scheffer, G. L., Ifergan, I., Scheper, R. J., Cloos, J., Assaraf, Y. G., and Jansen, G. (2006) Acquired resistance to chloroquine in human CEM T cells is mediated by multidrug resistance-associated protein 1 and provokes high levels of cross-resistance to glucocorticoids. Arthritis Rheum. 54, 557-568 (Pubitemid 43228632)
41. Takabe, K., Kim, R. H., Allegood, J. C., Mitra, P., Ramachandran, S., Nagahashi, M., Harikumar, K. B., Hait, N. C., Milstien, S., and Spiegel, S. (2010) Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. J. Biol. Chem. 285, 10477-10486
42. Zhu, H., Wu, H., Liu, X., Evans, B. R., Medina, D. J., Liu, C. G., and Yang, J. M. (2008) Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem. Pharmacol. 76, 582-588
43. Liang, Z., Wu, H., Xia, J., Li, Y., Zhang, Y., Huang, K., Wagar, N., Yoon, Y., Cho, H. T., Scala, S., and Shim, H. (2010) Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem. Pharmacol. 79, 817-824
44. Levchenko, A., Mehta, B. M., Niu, X., Kang, G., Villafania, L., Way, D., Polycarpe, D., Sadelain, M., and Larson, S. M. (2005) Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells. Proc. Natl. Acad. Sci. U. S. A. 102, 1933-1938 (Pubitemid 40261990)